↓ Skip to main content

The third-generation EGFR inhibitor AZD9291 overcomes primary resistance by continuously blocking ERK signaling in glioblastoma

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, May 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (75th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

blogs
1 blog
twitter
1 X user

Citations

dimensions_citation
86 Dimensions

Readers on

mendeley
106 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The third-generation EGFR inhibitor AZD9291 overcomes primary resistance by continuously blocking ERK signaling in glioblastoma
Published in
Journal of Experimental & Clinical Cancer Research, May 2019
DOI 10.1186/s13046-019-1235-7
Pubmed ID
Authors

Xuejiao Liu, Xiangyu Chen, Lin Shi, Qianqian Shan, Qiyu Cao, Chenglong Yue, Huan Li, Shengsheng Li, Jie Wang, Shangfeng Gao, Mingshan Niu, Rutong Yu

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 106 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 106 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 13 12%
Student > Bachelor 13 12%
Researcher 11 10%
Student > Master 11 10%
Student > Doctoral Student 5 5%
Other 15 14%
Unknown 38 36%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 23 22%
Medicine and Dentistry 12 11%
Pharmacology, Toxicology and Pharmaceutical Science 9 8%
Agricultural and Biological Sciences 6 6%
Neuroscience 5 5%
Other 13 12%
Unknown 38 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 February 2024.
All research outputs
#4,622,234
of 25,385,509 outputs
Outputs from Journal of Experimental & Clinical Cancer Research
#266
of 2,382 outputs
Outputs of similar age
#86,883
of 364,013 outputs
Outputs of similar age from Journal of Experimental & Clinical Cancer Research
#10
of 82 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,382 research outputs from this source. They receive a mean Attention Score of 4.8. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 364,013 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 82 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.